Munafa technical analysis Agios Pharmaceuticals, Inc. AGIO technical analysis buy or sell

Munafa technical analysis Agios Pharmaceuticals, Inc. AGIO technical analysis buy or sell Analysis of Agios Pharmaceuticals, Inc. AGIO to buy or sell for Daily, weekly or monthly

Quick Chart Bull Charts Forecast Tomorrow Price Targets View Analysis

Agios Pharmaceuticals, Inc. AGIO Daily Analysis to buy or sell

As per my analysis of Agios Pharmaceuticals, Inc. AGIO, 12 day returns for Agios Pharmaceuticals, Inc. AGIO have been positive, with total returns of 2.01, which is 6.01% with investment starting at 33.46.
An investment of 100,000 bucks in Agios Pharmaceuticals, Inc. would have become 106010 bucks today.

Agios Pharmaceuticals, Inc. AGIO moves in a range of 0.5 points on a day to day basis. This means that a total of approx 0.5 plus points of returns can be expected in a bullish day, and a total of 0.5 minus points can be expected in a bearish day.
This is about 1.41% of returns per day.

Agios Pharmaceuticals, Inc. Munafa analysis, looking for Trend and BUY or SELL opportunities.

Stock is in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Agios Pharmaceuticals, Inc. AGIO at this time.

It appears as if Agios Pharmaceuticals, Inc. AGIO gave a large move recently.

Stock of Agios Pharmaceuticals, Inc. (AGIO) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

Although my analysis for Agios Pharmaceuticals, Inc. is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 35.4, for a target of 34.6 or 33.91

You can find more Price Targets here or Forecast here for Shortterm, Midterm, and Longterm

Daily Candle Stick analysis of Agios Pharmaceuticals, Inc. AGIO

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 24 Mon Feb 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 4.6 HC: 2 LC: 2.6 OC: 0.1

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Agios Pharmaceuticals, Inc. is forming a DOJI candle

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 21 Fri Feb 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 4.6 HC: 0.2 LC: 4.4 OC: 2.9

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 20 Thu Feb 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 2.3 HC: 0.7 LC: 1.5 OC: 0

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Agios Pharmaceuticals, Inc. is forming a DOJI candle

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 19 Wed Feb 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 3.5 HC: 1.4 LC: 2.1 OC: 3.5

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 19 Wed Feb 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 3.5 HC: 1.4 LC: 2.1 OC: 3.5

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Agios Pharmaceuticals, Inc. AGIO Weekly Analysis to buy or sell

As per my analysis of Agios Pharmaceuticals, Inc. AGIO, 12 week returns for Agios Pharmaceuticals, Inc. AGIO have been negative, with total returns of -0.43, which is -1.2% with investment starting at 35.90.
An investment of 100,000 bucks in Agios Pharmaceuticals, Inc. would have become 98800 bucks today.

Agios Pharmaceuticals, Inc. AGIO moves in a range of 1 points on a week to week basis. This means that a total of approx 1 plus points of returns can be expected in a bullish week, and a total of 1 minus points can be expected in a bearish week.
This is about 2.82% of returns per week.

Weekly Candle Stick analysis of Agios Pharmaceuticals, Inc. AGIO

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 24 Mon Feb 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 4.6 HC: 2 LC: 2.6 OC: 0.1

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Agios Pharmaceuticals, Inc. is forming a DOJI candle

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 21 Fri Feb 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 6.2 HC: 0.2 LC: 5.9 OC: 5.9

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 19 Wed Feb 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 5.1 HC: 2.5 LC: 2.5 OC: 4.1

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 14 Fri Feb 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 9.9 HC: 4.4 LC: 5.3 OC: 3.4

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 07 Fri Feb 2025 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 6.8 HC: 4.9 LC: 1.8 OC: 3.6

Agios Pharmaceuticals, Inc. is moving towards a low expiry

Agios Pharmaceuticals, Inc. AGIO Monthly Analysis to buy or sell

As per my analysis of Agios Pharmaceuticals, Inc. AGIO, 12 month returns for Agios Pharmaceuticals, Inc. AGIO have been positive, with total returns of 6.23, which is 21.31% with investment starting at 29.24.
An investment of 100,000 bucks in Agios Pharmaceuticals, Inc. would have become 121310 bucks today.

Agios Pharmaceuticals, Inc. AGIO moves in a range of 5.4 points on a month to month basis. This means that a total of approx 5.4 plus points of returns can be expected in a bullish month, and a total of 5.4 minus points can be expected in a bearish month.
This is about 15.22% of returns per month.

Monthly Candle Stick analysis of Agios Pharmaceuticals, Inc. AGIO

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 24 Mon Feb 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 14.6 HC: 2 LC: 12.4 OC: 6.8

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 31 Fri Jan 2025 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 14.7 HC: 4.7 LC: 9.6 OC: 8.1

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 27 Fri Dec 2024 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 71.9 HC: 69.4 LC: 1.5 OC: 0.8

Agios Pharmaceuticals, Inc. is moving towards a low expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 26 Tue Nov 2024 is showing a green candle, which means that the buyers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 44.7 HC: 5.9 LC: 36.7 OC: 37.3

Agios Pharmaceuticals, Inc. is moving towards a high expiry

Candle stick analysis of Agios Pharmaceuticals, Inc. as on 25 Fri Oct 2024 is showing a red candle, which means that the sellers are dominating this session.

Candle stick ratios of Agios Pharmaceuticals, Inc. are:
HL: 15.8 HC: 2.6 LC: 12.9 OC: 1.4

Agios Pharmaceuticals, Inc. is moving towards a high expiry